Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
Fred Yang,1 Murray Stewart,2 June Ye,2 David DeMets3 1AstraZeneca, Gaithersburg, MD, USA; 2GlaxoSmithKline, Upper Merion, PA, USA; 3Department of Biostatistics and Medical Informatics, University of Wisconsin–Madison, Madison, WI, USA Abstract: For type 2 diabetes mellitus treatment and cl...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/83d7c47aaf754534916efa4acf6f0be0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|